Sandra Strychor - Concepedia

Author

Sandra Strychor

University of Pittsburgh

Also Known As

Ramanathan, Ramesh K., S Strychor, S. STRYCHOR, S. Strychor, Sandra Strychor

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh UPMC Hillman Cancer Center Carlow University University of North Carolina at Chapel Hill Emory University

About

Sandra Strychor is an author at University of Pittsburgh specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	536
2	Health Sciences	5	5	167
3	Biochemistry	3	3	181
4	Cell Biology	3	3	153
5	Natural Sciences	1	1	115

Sandra Strychor

Publications

Citations

H-Index

Page 1

	Year	Citations
Clove Extract Inhibits Tumor Growth and Promotes Cell Cycle Arrest and Apoptosis Haizhou Liu, John C. Schmitz, Jianteng Wei, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics Eaec TreatmentMedicinal ChemistryPolyphenolicsCell Cycle DistributionGlioma	2014	115
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or <i>BRCA</i> Mutation–Associated Breast Cancer Eve T. Rodler, Brenda F. Kurland, Melissa Griffin, Clinical Cancer Research	2016	97
Changes in Brain Energy and Phospholipid Metabolism During Development and Aging in the Fischer 344 Rat Jay W. Pettegrew, Kanagasabai Panchalingam, G. P. WITHERS, Journal of Neuropathology & Experimental Neurology AgingBrain DevelopmentPhospholipid MetabolismBiogerontologyFischer 344	1990	91
Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts William C. Zamboni, Sandra Strychor, Erin Joseph, Clinical Cancer Research	2007	87
Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies William C. Zamboni, Suresh S. Ramalingam, David Friedland, Clinical Cancer Research	2009	62
Endothelin Receptor A Blockade Enhances Taxane Effects in Prostate Cancer Ardavan Akhavan, Kevin McHugh, Georgi Guruli, Neoplasia	2006	47
Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors William C. Zamboni, Lauren Maruca, Sandra Strychor, Journal of Liposome Research	2010	44
Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies W. Zamboni, Sandra Strychor, Lauren Maruca, Clinical Pharmacology & Therapeutics	2009	43
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes William C. Zamboni, Ramesh K. Ramanathan, Howard L. McLeod, Investigational New Drugs BiochemistryMedicinePharmacologyAbc Transporter GenotypesAntimicrobial Resistance	2006	42
Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer Suresh S. Ramalingam, R. Donald Harvey, Nabil F. Saba, Cancer	2010	39

Page 1